Freedom Holding Secures Turkish Brokerage License but Structural Headwinds Persist

What happened

Freedom Holding announced that its subsidiary Freedom Yatırım Menkul Değerler A.Ş. received an operating license from the Capital Markets Board of Türkiye (CMB), marking expansion into the Turkish market. This comes amid a challenging period for the group, as fiscal 2025 net income collapsed from $376 million in 2024 to $85 million due to regulatory changes, higher taxes, and trading losses in Kazakhstan. The master report highlights that FRHC trades at a trailing P/E of 165x with ROE near 7%, and faces concentration risk with a single market-maker accounting for 56% of fee income. While increased geographic diversification is positive, the Turkish license is unlikely to materially alter near-term earnings given the small scale relative to existing operations. The stock remains expensive with limited margin of safety, and the news does not address the core overhang of sanctions probes or capital-intensive losses in the telecom segment.

Implication

The new license in Türkiye adds another market for potential growth, but Türkiye itself presents high inflation, currency volatility, and regulatory complexity, which may dilute rather than enhance returns. Given the company's current valuation at ~165x trailing earnings and net margin near 0.3%, positive sentiment from the announcement is likely to be short-lived. The core issues - Kazakhstani regulatory headwinds, customer concentration, and loss-making ecosystem segments - are unchanged and will continue to pressure profitability. Until management demonstrates sustained earnings recovery and de-risking of the balance sheet, a long position is unattractive at current levels. Investors should consider trimming or avoiding FRHC above $130–135 and wait for a price closer to the $90 attractive entry level identified in the master report.

Thesis delta

The Turkish brokerage license is a modest positive for geographic diversification, but it does not address the structural earnings pressure or valuation excess identified in the master report. The thesis remains a POTENTIAL SELL with no change in conviction or target levels. Only a significant improvement in core profitability or a sharp de-rating would warrant a reassessment.